Search result for pharmaceutical
Pfizer shareholders may finally get the bargain of their dreams in Seagen.
The cancer drug maker's innovative approach makes it an attractive acquisition candidate for a pharmaceutical behemoth. According to reports, pharmaceutical giant Pfizer Inc. is negotiating an acquisition that would please the company's investors. The Wall Street Journal reported last nig...
Pharmaceutical reported top-line growth and a return to profitability on the bottom line
Gulf Pharmaceutical Industries (Julphar), situated in Ras Al Khaimah (RAK), has released its financial results for 2021. The firm recorded sales of Dhs1,143m, a 100% increase over the Dhs573m received in 2020.
The pharma firm credited the considerable gain to increasing market share in ...
Global Pharmaceutical Contract Sales Outsourcing (CSO) Market to Witness 8.7% Growth during 2021 - 2029
The Global Pharmaceutical Contract Sales Outsourcing (CSO) Market is projected to grow at a CAGR of 8.7% during the forecast period (2021 – 2029). The global pharmaceutical contract sales outsourcing (CSO) market is driven by the changing nature of the pharmaceutical industry with new...
Global Active Pharmaceutical Ingredient Market to Grow at Promising
The global active pharmaceutical ingredient market reached a robust valuation of US$ 172.14 billion in 2020. The market will exhibit strong growth, rising at 6% CAGR during the forecast (2021-2029) period. Companies such as Sanofi planned to create a major European company dedicated to the produc...
Global Pharmaceutical Quality Control Market was Valued at
Absolute Markets Insights (AMI) reports a robust forecast for the pharmaceutical quality control market during the 2021-2029 period. In its newly released report, AMI anticipates the market will grow at 13.85% as minimized disruption, transit time and costs are rapidly leading the market towards ...
JAPAN PHARMACEUTICAL ASSOCIATION OPPOSES TEMPORARY WAIVER OF PATENT ON VACCINE
Highlights –
- Japan pharmaceutical association opposes temporary waiver of patent on vaccine.
- It opposed U.S support for the temporary waiver of coronavirus vaccine patent rights.
- WTO is currently discussing the waiver of patent rights...
CHINA TO PRODUCE COVID-19 VACCINE FOR 70% OF ITS POPULATION
Highlights –
- China to produce COVID-19 vaccine for 70% of its population.
- China is trying to reshape its pharmaceutical industry.
- More than 100 million doses had been exported by March.
- Biotec has produced 250 million doses...
CELLTRION WILL SUPPLY ITS COVID-19 TREATMENT WITHOUT PROFIT MARGIN IN S. KOREA
Highlights –
- Celltrion will supply its COVID-19 treatment without profit margin in S. Korea.
- Celltrion’s CT-P59 began to be supplied to local medical institutions on Wednesday.
- The company has also planned to supply the treatmen...
CELLTRION’S COVID-19 ANTIBODY TREATMENT CONFIRMED TO NEUTRALIZE VIRUS VARIANT
Highlights –
- Celltrion’s COVID-19 antibody treatment confirmed to neutralize virus variant.
- The company’s CT-P59, an anti-COVID-19 monoclonal antibody treatment neutralized the British virus variant.
- The company has also t...
JAPAN’S KOBAYASHI KAKO CO. RECEIVES AN ORDER TO SUSPEND BUSINESS FOR 116 DAYS
Highlights –
- Japan’s Kobayashi Kako Co. receives an order to suspend business for 116 days.
- The company was guilty of making fictitious production records on nearly 80 percent of its products.
- The company last year had recalled ...
PHARMACEUTICAL STRATEGY OF EUROPEAN COMMISSION HAILED BY HEALTHCARE DISTRIBUTORS
Highlights:
- The pharmaceutical strategy of the European Commission has been hailed by the distributors of Healthcare
- The strategy is aiming to make sure that, the patients have the access to the affordable and innovative medicines
As...
WARREN BUFFET'S BERKSHIRE HATHWAY INVESTS HUGE MONEY IN US PHARMA COMPANIES
Highlights
• Berkshire Hathaway, the investment company owned by Warren Buffet has decided to place its bets on pharmaceutical companies in the U.S.
• According to the Bloomberg Billionaires Index, courtesy of these investments, the net worth of Buffet surged to $88 ...
BACTERIAL INFECTION PLAGUES NORTHWEST CHINA IN SEVERE OUTBREAK FROM BIOPHARMA LEAK
- Several thousand people in northwest China took being plagued with a bacterial disease by testing positive for it, authorities said on Tuesday, in a massive outbreak caused by a leak at a biopharmaceutical company last year.
- The Health Advisory of Lanzhou, the capital of Gansu ...
TAKEDA AIMS TO GO PUBLIC IN THE NEXT 5 TO 10 YEARS AFTER BLACKSTONE’S ACQUISITION
Highlights –
- Takeda Pharmaceutical aims to go public in the next 5 to 10 years after Blackstone’s acquisition.
- The unit needs to expand its business overseas in Chinese-speaking markets.
- Takeda plans to sell its drug unit to Bl...
TAKEDA CO. PLANNING TO SELL ITS OTC MEDICINE UNIT TO U.S BLACKSTONE GROUP INC.
Highlights –
- Takeda Co. planning to sell its OTC medicine unit to U.S Blackstone Group Inc.
- Takeda plans on selling the same for around $2.9 billion.
- Takeda aims to reduce its debt of $5.86 billion after its purchase of Shire Plc.
TAKEDA PHARMACEUTICAL CO.RAISED ITS NET PROFIT OUTLOOK FOR THIS YEAR
Highlights –
- Takeda pharmaceutical co. raised its net profit outlook for this year.
- The drug-making company revised its bottom-line outlook to $880 million.
- It also reported an operating profit outlook to $374 million.
- Tak...
LONDON – LISTED SHARES ROSE ON WEDNESDAY
Highlights –
- London-listed shares rose on Wednesday.
- Pharmaceutical companies saw the most gains.
- The blue-chip FTSE 100 .FTSE was up 1.0%.
- Online fashion retailer ASOS (ASOS.L) shares jumped by 2.8%.
On ...
SANTEN OBTAINS US FDA ACCEPTANCE OF PMA APPLICATION FOR DE-128
HIGHLIGHTS
- Santen Pharmaceutical Co., Ltd. has submitted the Premarket Approval (PMA) application for DE-128 (MicroShunt) for review.
- US FDA has accepted the application from Santen.
- DE-128 is an investigational surgical glaucoma implant.
WALL STREET INVESTORS ARE LIKELY TO SHIFT TO LARGE PHARMACEUTICAL COMPANIES
Highlights –
- Wall Street investors are likely to shift to large pharmaceutical companies.
- Investors are moving away from their investment from small biotech firms.
- Big pharma companies are racing over production of COVID-19 vaccines.<...
EUROPEAN UNION CALLS MEMBER STATES TO LIFT BAN ON INSULIN EXPORT
Highlights
• Export of drugs like Hydroxychloroquine have been banned by numerous European countries
• Medical experts have criticised the decision of ban on insulin export
After several rumours which said that coronavirus pandemic would cause shortages of ...